Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,057 | 152 | 99.3% |
| Education | $52.51 | 6 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,547 | 57 | $0 (2022) |
| Amgen Inc. | $1,211 | 25 | $0 (2019) |
| AbbVie Inc. | $924.86 | 13 | $0 (2020) |
| Pfizer Inc. | $687.23 | 16 | $0 (2020) |
| GENZYME CORPORATION | $540.37 | 5 | $0 (2019) |
| Horizon Pharma plc | $354.38 | 3 | $0 (2018) |
| Genentech USA, Inc. | $348.82 | 9 | $0 (2019) |
| MEDAC PHARMA, INC. | $230.93 | 7 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $221.80 | 3 | $0 (2019) |
| GlaxoSmithKline, LLC. | $204.90 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $140.10 | 2 | Novartis Pharmaceuticals Corporation ($123.21) |
| 2021 | $212.63 | 4 | Novartis Pharmaceuticals Corporation ($212.63) |
| 2020 | $662.38 | 17 | AbbVie Inc. ($240.54) |
| 2019 | $1,648 | 34 | Amgen Inc. ($484.59) |
| 2018 | $2,277 | 57 | Novartis Pharmaceuticals Corporation ($593.35) |
| 2017 | $2,169 | 44 | Amgen Inc. ($439.28) |
All Payment Transactions
158 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/22/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 02/08/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $123.21 | General |
| Category: IMMUNOLOGY | ||||||
| 09/09/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $99.94 | General |
| Category: IMMUNOLOGY | ||||||
| 07/08/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $95.49 | General |
| Category: IMMUNOLOGY | ||||||
| 03/19/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $9.20 | General |
| Category: IMMUNOLOGY | ||||||
| 02/18/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/23/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $8.09 | General |
| Category: IMMUNOLOGY | ||||||
| 10/05/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: IMMUNOLOGY | ||||||
| 08/31/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $9.20 | General |
| Category: IMMUNOLOGY | ||||||
| 06/30/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $9.20 | General |
| Category: IMMUNOLOGY | ||||||
| 06/16/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $9.02 | General |
| Category: IMMUNOLOGY | ||||||
| 03/11/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $118.80 | General |
| Category: IMMUNOLOGY | ||||||
| 03/09/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: IMMUNOLOGY | ||||||
| 02/27/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $102.47 | General |
| Category: IMMUNOLOGY | ||||||
| 02/27/2020 | AbbVie Inc. | HUMIRA (Biological) | Education | In-kind items and services | $7.29 | General |
| Category: IMMUNOLOGY | ||||||
| 02/11/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $9.20 | General |
| Category: IMMUNOLOGY | ||||||
| 02/04/2020 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $104.01 | General |
| Category: Endocrinology | ||||||
| 01/30/2020 | AbbVie Inc. | RINVOQ (Drug) | Food and Beverage | In-kind items and services | $123.49 | General |
| Category: IMMUNOLOGY | ||||||
| 01/30/2020 | AbbVie Inc. | RINVOQ (Drug) | Education | In-kind items and services | $7.29 | General |
| Category: IMMUNOLOGY | ||||||
| 01/15/2020 | Pfizer Inc. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $90.11 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 01/15/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: IMMUNOLOGY | ||||||
| 01/06/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $81.10 | General |
| 11/13/2019 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $100.32 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 7 | 255 | 695 | $96,344 | $18,718 |
| 2021 | 11 | 472 | 1,080 | $167,050 | $41,152 |
| 2020 | 13 | 671 | 1,879 | $269,570 | $58,178 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 90 | 97 | $35,890 | $8,301 | 23.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 52 | 56 | $26,702 | $7,465 | 28.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 13 | 21 | $6,452 | $1,194 | 18.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 18 | $4,716 | $919.23 | 19.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 30 | 56 | $4,791 | $544.44 | 11.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 42 | 381 | $15,610 | $274.32 | 1.8% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 14 | 66 | $2,183 | $21.07 | 1.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 139 | 182 | $67,340 | $17,912 | 26.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 57 | 73 | $34,809 | $9,978 | 28.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 29 | 35 | $5,005 | $2,815 | 56.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 27 | 37 | $9,694 | $2,609 | 26.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $7,966 | $1,849 | 23.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 27 | 33 | $3,267 | $1,541 | 47.2% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 15 | 28 | $8,349 | $1,502 | 18.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 59 | 133 | $11,379 | $1,402 | 12.3% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2021 | 52 | 173 | $5,373 | $1,280 | 23.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 23 | 198 | $8,112 | $203.04 | 2.5% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2021 | 30 | 174 | $5,756 | $60.88 | 1.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 165 | 242 | $89,540 | $19,810 | 22.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 85 | 108 | $51,498 | $11,557 | 22.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 34 | 34 | $23,789 | $5,995 | 25.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 29 | 39 | $5,577 | $3,637 | 65.2% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 24 | 53 | $16,572 | $2,838 | 17.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 67 | 245 | $20,962 | $2,714 | 12.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 36 | 45 | $11,790 | $2,696 | 22.9% |
About Dr. Michael Barger, M.D
Dr. Michael Barger, M.D is a Rheumatology healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124125208.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Barger, M.D has received a total of $7,110 in payments from pharmaceutical and medical device companies, with $140.10 received in 2022. These payments were reported across 158 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($7,057).
As a Medicare-enrolled provider, Barger has provided services to 1,398 Medicare beneficiaries, totaling 3,654 services with total Medicare billing of $118,048. Data is available for 3 years (2020–2022), covering 31 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location Sacramento, CA
- Active Since 09/20/2006
- Last Updated 02/09/2012
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1124125208
Products in Payments
- COSENTYX (Biological) $1,427
- Enbrel (Biological) $865.76
- XELJANZ (Drug) $687.23
- KEVZARA (Drug) $662.35
- Humira (Biological) $430.41
- KRYSTEXXA (Drug) $354.38
- Actemra (Biological) $348.82
- Rasuvo (Drug) $230.93
- BENLYSTA (Biological) $204.90
- Cimzia (Drug) $161.57
- RINVOQ (Drug) $130.78
- STELARA (Biological) $124.99
- ILARIS (Biological) $119.33
- Prolia (Biological) $110.29
- HUMIRA (Biological) $109.76
- Tymlos (Biological) $104.01
- RHEUMATOID ARTHRITIS DISEASE (Drug) $99.82
- TALTZ (Drug) $98.61
- Otezla (Drug) $92.55
- ORENCIA (Biological) $80.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Sacramento
Dr. Douglas Roberts, M.d, M.D
Rheumatology — Payments: $30,421
Dr. David Lehman, M.d, M.D
Rheumatology — Payments: $23,673
Dr. Kristen Lee, Md, MD
Rheumatology — Payments: $9,845
Janahn Scalapino, Md, MD
Rheumatology — Payments: $3,414
Dr. Kenneth Wiesner, M.d, M.D
Rheumatology — Payments: $2,487
Dr. Bob Shapiro, M.d, M.D
Rheumatology — Payments: $979.91